TY - JOUR
T1 - −295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple’s disease
AU - Biagi, F.
AU - Schiepatti, A.
AU - Badulli, C.
AU - Sbarsi, I.
AU - Trotta, L.
AU - Feurle, G. E.
AU - Müller, C.
AU - Moos, V.
AU - Schneider, T.
AU - Marth, T.
AU - De Amici, M.
AU - Martinetti, M.
AU - Corazza, G. R.
PY - 2015/7/8
Y1 - 2015/7/8
N2 - Whipple’s disease (WD) is a rare systemic condition caused, in genetically predisposed subjects, by Tropheryma whipplei, a common bacterium widespread in the environment. The relevance of genetic predisposition in WD is shown by the association with HLA alleles DRB1*13 and DQB1*06 and by the demonstration that, in patients with WD, the cytokine genetic profile is skewed toward a Th2 and Treg response. Since IL-16 is involved in hampering the development of a protective macrophagic response against Tropheryma whipplei, we investigated whether the genetic background of IL-16 is different between patients with WD and controls. The −295 T-to-C polymorphism of the promoter region of the IL-16 gene was studied in 90 patients with WD and 152 healthy controls. Levels of serum IL-16 protein were also tested. The frequency of the wild type T allele was significantly higher in patients with WD compared to the controls (155/180 vs. 235/304; p = 0.02 for the Chi2 test), odds ratio 1.82 [95 % confidence interval (CI) 1.07–3.10]. The TT genotype was found in 65/90 patients with WD and 88/152 controls (p = 0.026). No relationship was found between serum levels of IL-16 and genotypes. Although the functional consequences of this genetic background on levels of IL-16 and on the course of the disease are still unknown, we found, for the first time, that the wild type T allele and the TT genotype of the −295 polymorphism are associated with WD.
AB - Whipple’s disease (WD) is a rare systemic condition caused, in genetically predisposed subjects, by Tropheryma whipplei, a common bacterium widespread in the environment. The relevance of genetic predisposition in WD is shown by the association with HLA alleles DRB1*13 and DQB1*06 and by the demonstration that, in patients with WD, the cytokine genetic profile is skewed toward a Th2 and Treg response. Since IL-16 is involved in hampering the development of a protective macrophagic response against Tropheryma whipplei, we investigated whether the genetic background of IL-16 is different between patients with WD and controls. The −295 T-to-C polymorphism of the promoter region of the IL-16 gene was studied in 90 patients with WD and 152 healthy controls. Levels of serum IL-16 protein were also tested. The frequency of the wild type T allele was significantly higher in patients with WD compared to the controls (155/180 vs. 235/304; p = 0.02 for the Chi2 test), odds ratio 1.82 [95 % confidence interval (CI) 1.07–3.10]. The TT genotype was found in 65/90 patients with WD and 88/152 controls (p = 0.026). No relationship was found between serum levels of IL-16 and genotypes. Although the functional consequences of this genetic background on levels of IL-16 and on the course of the disease are still unknown, we found, for the first time, that the wild type T allele and the TT genotype of the −295 polymorphism are associated with WD.
UR - http://www.scopus.com/inward/record.url?scp=84940435056&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940435056&partnerID=8YFLogxK
U2 - 10.1007/s10096-015-2433-7
DO - 10.1007/s10096-015-2433-7
M3 - Article
C2 - 26154181
AN - SCOPUS:84940435056
SN - 0934-9723
VL - 34
SP - 1919
EP - 1921
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
IS - 9
ER -